Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_assertion description "[The validated primary endpoint assay, a peptide-specific CD8+ IFNgamma ELISPOT, was tested in a pre-trial study and found to be suitable for the detection of low frequency naturally occurring CEA- and prostate-derived tumour-antigen-specific T cells in patients with CEA-expressing malignancies and prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_assertion evidence source_evidence_literature NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_assertion SIO_000772 19066888 NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_assertion wasDerivedFrom befree-20150227 NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_assertion wasGeneratedBy ECO_0000203 NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP991975.RA7UCFaP4J0RkUl0b89lwxWD5-2pbW1GQq12n7esd1jUI130_provenance.